Why the study?
Hip fractures remain challenging for patients on direct oral anticoagulants, and the impact of DOACs and their concentration on postoperative mortality after hip fracture surgery required evaluation.
Does DOAC use impact mortality and transfusion rates in patients aged >65 years undergoing hip fracture surgery?
Does DOAC use impact mortality and transfusion rates in patients aged >65 years undergoing hip fracture surgery?
In older adults undergoing hip fracture surgery, prior DOAC use is associated with higher mortality up to 180 days, despite similar transfusion rates compared to non-users.
Prior DOAC use may signal higher 180-day mortality after hip fracture surgery; leaves open optimal perioperative strategies.
No takes yet. Share an insight, caveat, or question.
Gricourt et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: